AI Engines For more Details: Perplexity Kagi Labs You
Adrenal Insufficiency: Cortisol acetate is primarily used in the management of adrenal insufficiency, a condition characterized by inadequate production of cortisol and other adrenal hormones. Adrenal insufficiency may result from primary adrenal gland dysfunction (such as Addison's disease) or secondary adrenal insufficiency due to pituitary or hypothalamic disorders. Cortisol acetate supplementation helps restore cortisol levels to physiological ranges, thereby alleviating symptoms such as fatigue, weakness, weight loss, hypotension, and electrolyte imbalances.
Anti-inflammatory Effects: Cortisol acetate, like natural cortisol, has potent anti-inflammatory properties and is used to suppress inflammation in various medical conditions. It helps reduce inflammation, swelling, and pain associated with inflammatory disorders such as rheumatoid arthritis, lupus, inflammatory bowel disease, and dermatitis. Cortisol acetate works by inhibiting the production of inflammatory mediators and suppressing the immune response.
Immunosuppression: Cortisol acetate exerts immunosuppressive effects by inhibiting the activity of immune cells and reducing the production of inflammatory cytokines. It is used in the management of autoimmune disorders, organ transplantation (to prevent rejection), and allergic reactions. By suppressing the immune response, cortisol acetate helps prevent tissue damage and attenuate symptoms associated with immune-mediated conditions.
Stress Response: Cortisol acetate is sometimes used in the management of acute stress situations, such as severe illness, trauma, surgery, or critical care. It helps stabilize hemodynamics, maintain blood pressure, and modulate the body's response to stress by increasing glucose availability, enhancing vascular tone, and suppressing inflammation. Cortisol acetate may be administered intravenously or orally in acute stress settings to support adrenal function and prevent adrenal crisis.
Dosage and Administration: Cortisol acetate is available in various formulations, including oral tablets, intravenous injections, and topical preparations. The dosage and duration of cortisol acetate therapy depend on factors such as the specific medical condition being treated, the severity of symptoms, and the individual patient's response to treatment. Cortisol acetate is typically administered in divided doses to mimic the body's natural cortisol secretion pattern and minimize the risk of adverse effects.
Side Effects: Cortisol acetate therapy may be associated with a range of potential side effects, particularly with long-term or high-dose use. Common side effects may include weight gain, fluid retention, increased appetite, mood changes, insomnia, gastrointestinal upset, acne, skin thinning, easy bruising, and increased susceptibility to infections. Long-term cortisol acetate use may also be associated with more serious side effects, including osteoporosis, diabetes, hypertension, cataracts, glaucoma, adrenal suppression, and increased risk of opportunistic infections.
Contraindications and Precautions: Cortisol acetate is contraindicated in individuals with known hypersensitivity to corticosteroids or any of their components. It should be used with caution in patients with certain medical conditions, including diabetes, hypertension, osteoporosis, peptic ulcer disease, psychiatric disorders, and infections. Cortisol acetate therapy should be tapered gradually when discontinuing treatment to avoid adrenal insufficiency or withdrawal symptoms.
Rank | Probiotic | Impact |
---|
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
ADHD | 0.4 | 0.4 | |
Allergic Rhinitis (Hay Fever) | 0 | 0 | |
Allergies | 0.1 | 0.4 | -3 |
Allergy to milk products | 0.1 | 0 | 0 |
Alzheimer's disease | 0.1 | 1 | -9 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.1 | -0.1 | |
Ankylosing spondylitis | 0 | 0.1 | 0 |
Anorexia Nervosa | 0.1 | 0.4 | -3 |
Asthma | 0 | 0 | 0 |
Atherosclerosis | 0.1 | 0.1 | |
Atrial fibrillation | 0.4 | 0.6 | -0.5 |
Autism | 0.3 | 0.8 | -1.67 |
benign prostatic hyperplasia | 0 | 0 | |
Bipolar Disorder | 0.1 | 0.1 | 0 |
Brain Trauma | 0.1 | -0.1 | |
Carcinoma | 0.1 | 0.1 | 0 |
Celiac Disease | 0.1 | 0.1 | 0 |
Cerebral Palsy | 0 | 0.1 | 0 |
Chronic Fatigue Syndrome | 0.4 | 0.8 | -1 |
Chronic Kidney Disease | 0 | 0.6 | 0 |
Chronic Lyme | 0 | 0 | |
Coagulation / Micro clot triggering bacteria | 0.1 | -0.1 | |
Cognitive Function | 0.1 | 0.1 | |
Colorectal Cancer | 0.3 | 0.4 | -0.33 |
Constipation | 0.3 | 0.3 | |
Coronary artery disease | 0.4 | 0.6 | -0.5 |
COVID-19 | 0.3 | 1.4 | -3.67 |
Crohn's Disease | 0.3 | 0.7 | -1.33 |
Cushing's Syndrome (hypercortisolism) | 0.1 | -0.1 | |
cystic fibrosis | 0 | 0 | |
deep vein thrombosis | 0.1 | -0.1 | |
Depression | 0.3 | 1 | -2.33 |
Endometriosis | 0 | 0.1 | 0 |
Epilepsy | 0 | 0 | 0 |
erectile dysfunction | 0 | 0 | |
Fibromyalgia | 0 | 0 | |
Functional constipation / chronic idiopathic constipation | 0.3 | 0.1 | 2 |
gallstone disease (gsd) | 0.1 | 0.1 | |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.1 | 0.1 | |
Generalized anxiety disorder | 0 | 0 | 0 |
Gout | 0.2 | 0.2 | |
Graves' disease | 0.1 | 0.1 | 0 |
Halitosis | 0 | 0 | |
Hashimoto's thyroiditis | 0.1 | 0 | 0 |
Heart Failure | 0.1 | 0.7 | -6 |
Hidradenitis Suppurativa | 0 | 0 | |
High Histamine/low DAO | 0.1 | -0.1 | |
hyperglycemia | 0 | 0 | |
hypertension (High Blood Pressure | 0.1 | 0.1 | 0 |
Hypoxia | 0 | 0 | |
IgA nephropathy (IgAN) | 0.1 | 0.1 | |
Inflammatory Bowel Disease | 0.1 | 1.2 | -11 |
Insomnia | 0 | 0.4 | 0 |
Intelligence | 0 | 0 | |
Intracranial aneurysms | 0.1 | 0.1 | |
Irritable Bowel Syndrome | 0.1 | 0.3 | -2 |
ischemic stroke | 0.1 | 0.3 | -2 |
Liver Cirrhosis | 0.4 | 0.1 | 3 |
Long COVID | 0.4 | 0.7 | -0.75 |
Lung Cancer | 0.1 | -0.1 | |
Mast Cell Issues / mastitis | 0.1 | -0.1 | |
ME/CFS with IBS | 0 | 0 | |
ME/CFS without IBS | 0 | 0 | |
Metabolic Syndrome | 0.1 | 0.3 | -2 |
Mood Disorders | 0.1 | 1 | -9 |
Multiple Sclerosis | 0.2 | 0.7 | -2.5 |
Multiple system atrophy (MSA) | 0.1 | -0.1 | |
neuropathic pain | 0 | 0 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.1 | 0.7 | -6 |
NonCeliac Gluten Sensitivity | 0 | 0 | 0 |
Obesity | 0.1 | 0.1 | 0 |
obsessive-compulsive disorder | 0.4 | 0.3 | 0.33 |
Osteoarthritis | 0 | 0.1 | 0 |
Osteoporosis | 0.1 | 0 | 0 |
Parkinson's Disease | 0.3 | 1 | -2.33 |
Polycystic ovary syndrome | 0.5 | 0.4 | 0.25 |
Primary sclerosing cholangitis | 0 | 0.1 | 0 |
Psoriasis | 0.1 | 0.6 | -5 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.4 | 0.6 | -0.5 |
Rosacea | 0.1 | 0.1 | |
Schizophrenia | 0.1 | 0.1 | 0 |
scoliosis | 0.1 | -0.1 | |
Sjögren syndrome | 0.3 | -0.3 | |
Sleep Apnea | 0.1 | 0 | 0 |
Slow gastric motility / Gastroparesis | 0.1 | 0.1 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 0 | 0 | |
Stress / posttraumatic stress disorder | 0 | 0 | 0 |
Systemic Lupus Erythematosus | 0 | 0.1 | 0 |
Tic Disorder | 0.2 | 0.2 | |
Tourette syndrome | 0 | 0 | |
Type 1 Diabetes | 0.3 | 0.3 | 0 |
Type 2 Diabetes | 0.6 | 0.3 | 1 |
Ulcerative colitis | 0.1 | 0.3 | -2 |
Unhealthy Ageing | 0.1 | 0.6 | -5 |
Vitiligo | 0.1 | 0.1 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]